side effects of glp 1 agonists Exploring the GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Many patients taking glucagon-like peptide-1

While true generic GLP-1 drugs have not been approved by the FDA, compounded semaglutide and tirzepatide from licensed 503A pharmacies deliver the same pharmaceutical compounds at substantially lower prices without requiring insurance or membership fees

Zhou J, Montrose-Rafizadeh C, Janczewski AM, Pineyro MA, Sollott SJ, Wang Y, and Egan JM

Miyazono K, Heldin C-H

Weight loss medications work by suppressing your appetite, curbing cravings, boosting your metabolism, or preventing your body from absorbing some of the fat you eat

Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications

Methodology This KFF Health Tracking Poll/Health Misinformation Tracking Poll was designed and analyzed by public opinion researchers at KFF